论文部分内容阅读
目的:探讨应用还原型谷胱甘肽治疗病毒性肝炎的临床效果。方法:选取138例病毒性肝炎患者,将其分为对照组和观察组,对照组69例,给予该组患者异甘草酸镁进行治疗,观察组69例,给予该组患者还原型谷光甘肽进行治疗,比较两组患者的治疗效果。结果:观察组治疗的有效率为92.75%,对照组治疗的有效率为89.86%,观察组治疗的效果明显优于对照组(P<0.05)。两组患者治疗后肝功能指标均较治疗前明显改善P<0.05)。结论:在病毒性肝炎的治疗中应用还原型谷光甘肽效果较为显著,安全性能较高,同时治疗中还应注意防范继发性感染,注意观察患者是否存在尿路感染、肺炎、腹膜炎等症状。
Objective: To investigate the clinical effect of reducing glutathione in the treatment of viral hepatitis. Methods: 138 patients with viral hepatitis were selected and divided into control group and observation group. In the control group, 69 patients were given magnesium isoglycyrrhizinate, and 69 patients in observation group were treated with reduced glutathione, The treatment effect of two groups of patients was compared. Results: The effective rate of observation group was 92.75%. The effective rate of control group was 89.86%. The effect of observation group was better than that of control group (P <0.05). Two groups of patients after treatment, liver function indicators were significantly improved than before treatment P <0.05). Conclusion: The application of reduced glutathione in the treatment of viral hepatitis has obvious effect and high safety performance. At the same time, it should pay attention to the prevention of secondary infection and pay attention to whether the patients have the symptoms of urinary tract infection, pneumonia and peritonitis .